Drugs / siSPARC
last change Nov 2024 re-read 3 minutes ago

siSPARC

targets SPARC via inhibition

Developed for
keloid
Investigated by
National Skin Centre

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06138964 Nov 2023 → Nov 2024 keloid National Skin Centre Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as siSPARC ClinicalTrials.gov intervention name — accepted as the source's own label NCT06138964 ↗
Action Inhibit “Small Interfering RNA Against SPARC (siSPARC)” NCT06138964 ↗
Target SPARC “Small Interfering RNA Against SPARC (siSPARC)” NCT06138964 ↗